Clinical Trials Browser

NCT07405086 2026-05-22

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis

Clinical Trials

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

OPTIVISMO-1

Skin Subs vs Secondary Intention

Suzetrigine vs Norco-postoperative Mohs Pain

MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.

SuRage-EB

ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

EPITOP-01

Meloxicam in Mohs Micrographic Surgery

Efficacy and Safety of Cryotherapy Versus 5-Fluorouracil in the Treatment of Actinic Keratosis

PAIR

CALM

PROSKIN

BLESS

SPIRAL

Cryotherapy in Combination with Red Light PDT for Actinic Keratosis of Full Face

Duration of Ameluz Application in Acral Actinic Keratoses Response

Study of Daylight Photodynamic Therapy With Aminolevulinic Acid for Actinic Keratoses

Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis on the Back of the Hands

NIVOPTIMIZE

SunDamage

Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage

Evolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1

Ipi4

MelanooMSOT

VAPOR-C

Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin Cancer

Comparison of Two Modes of Photodynamic Therapy for the Treatment of Actinic Keratosis on the Upper Extremities

Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients

Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream

VISORB

MentholPDT

Daylight-PDT With MAL for AK and Photodamaged Skin

SENTINELSEEK

Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Cutaneous Stage L-lll Melanoma

Efficacy of Ingenol Mebutate on Actinic Keratoses and Field Cancerization vs Cryotherapy

Evaluate the Efficacy and Safety of Large-Scale Field-Directed Topical Therapy of Actinic Keratosis of the Chest w/Ingenol Mebutate 0.015%

Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)

Evaluating Skin Appearance Following 5-Flourouracil Cream for Treatment of Actinic Keratosis and the Effects of Topical Agents

Aminolevulinic Acid-photodynamic Therapy for Facial Actinic Keratosis Treatment and Prevention

Clinical Trial to Evaluate Biafine Cream Versus Standard Care in Subjects With Actinic Keratosis Post Cryotherapy

Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy According to the Laser Density for Actinic Keratosis

Photodynamic Therapy of Actinic Keratosis of the Face and Scalp With and Without Prior Curettage

Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population

Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A

Clinical Trial of Ingenol Mebutate Gel 0.015% & 0.05% in Actinic Keratosis

Can We Miss Pigmented Lesions in Psoriasis Patients?

CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma

Akti